Erythema induratum is a skin condition that is characterized by inflammation and hardening of the skin, usually occurring on the calves of the legs. It is also known as Bazin's disease. The condition typically affects young women and is thought to be related to tuberculosis infection.

The symptoms of erythema induratum include red, painful, and hard nodules or plaques on the skin that may ulcerate and form crusts. These lesions can be tender to the touch and may cause scarring. The condition often affects both legs and can be accompanied by fever, fatigue, and other systemic symptoms of tuberculosis.

The diagnosis of erythema induratum is typically made based on the clinical presentation of the skin lesions and confirmed with laboratory tests such as a biopsy or culture to detect tuberculosis infection. Treatment usually involves antibiotics to treat the underlying tuberculosis infection, as well as anti-inflammatory medications to manage the skin symptoms. In some cases, surgical removal of the lesions may be necessary.

Cutaneous tuberculosis (CTB) is a rare form of tuberculosis that affects the skin. It is caused by the Mycobacterium tuberculosis complex, including M. tuberculosis, M. bovis, and M. africanum. CTB can occur as a primary infection after direct inoculation of the skin with the bacteria, or it can be secondary to a distant focus of infection such as lung or lymph node TB.

The clinical presentation of CTB is varied and can include papules, nodules, pustules, ulcers, plaques, or scaly lesions. The lesions may be painless or painful, and they can be associated with systemic symptoms such as fever, night sweats, and weight loss.

CTB can be diagnosed through a combination of clinical examination, skin biopsy, culture, and PCR testing. Treatment typically involves a prolonged course of multiple antibiotics, often for six to nine months or more. The most commonly used drugs are isoniazid, rifampin, ethambutol, and pyrazinamide. Surgical excision may be necessary in some cases.

Prevention measures include early detection and treatment of pulmonary TB, BCG vaccination, and avoiding contact with people with active TB.

Female genital tuberculosis (FGTB) is a specific form of tuberculosis (TB) that affects the female reproductive organs. It is caused by the bacterium Mycobacterium tuberculosis, which primarily affects the lungs (pulmonary TB) but can spread to other parts of the body through the bloodstream or lymphatic system.

In FGTB, the bacteria typically infect the fallopian tubes, uterus, ovaries, and/or the cervix, leading to various gynecological symptoms. The infection can cause scarring, blockage of the fallopian tubes, and damage to the reproductive organs, which may result in infertility, ectopic pregnancy, or chronic pelvic pain.

FGTB is often asymptomatic or has non-specific symptoms, making it difficult to diagnose. Common symptoms include irregular menstrual bleeding, postmenopausal bleeding, vaginal discharge, and pelvic pain. Diagnosis typically involves a combination of clinical examination, imaging studies (such as ultrasound or CT scan), and laboratory tests (such as endometrial biopsy, PCR, or culture).

FGTB is usually treated with a standard anti-tuberculosis drug regimen that includes isoniazid, rifampicin, ethambutol, and pyrazinamide for at least six months. In some cases, surgery may be required to manage complications such as hydrosalpinx or chronic pelvic pain. Preventing the spread of pulmonary TB through early detection and treatment is crucial in preventing FGTB.

Erythema is a term used in medicine to describe redness of the skin, which occurs as a result of increased blood flow in the superficial capillaries. This redness can be caused by various factors such as inflammation, infection, trauma, or exposure to heat, cold, or ultraviolet radiation. In some cases, erythema may also be accompanied by other symptoms such as swelling, warmth, pain, or itching. It is a common finding in many medical conditions and can vary in severity from mild to severe.

Erythema nodosum is a type of inflammation that occurs in the fatty layer of the skin, causing painful, red or purple bumps (nodules) to form. It is a type of panniculitis, which refers to any condition that causes inflammation of the fatty layer of tissue beneath the skin.

Erythema nodosum is often associated with a variety of underlying conditions, such as infections (e.g., streptococcus, tuberculosis), medications (e.g., sulfa drugs, oral contraceptives), inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis), and pregnancy.

The bumps associated with erythema nodosum typically appear on the shins, ankles, knees, or other areas of the legs, although they can also occur on the arms, hands, or face. The bumps may be tender to the touch, warm, and swollen, and they may cause pain or discomfort when walking or standing for prolonged periods.

In most cases, erythema nodosum resolves on its own within a few weeks to several months, although symptoms can be managed with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. Treating the underlying condition is also important for resolving erythema nodosum and preventing recurrences.